Document is current
Any future updates will be listed below
-
Authors
Carrà, Giovanna
Ermondi, Giuseppe
Riganti, Chiara
Righi, Luisella
Caron, Giulia
Menga, Alessio
Capelletto, Enrica
Maffeo, Beatrice
Lingua, Marcello Francesco
Fusella, Federica
Volante, Marco
Taulli, Riccardo
Guerrasio, Angelo
Novello, Silvia
Brancaccio, Mara
Piazza, Rocco
Morotti, Alessandro https://orcid.org/0000-0002-8407-2903
-
Funding
Funding for this research was provided by:
Ministero della Salute (GR-2011-02351167)
Associazione Italiana per la Ricerca sul Cancro (IG-22082, Start-Up Grant-15405)
- License Information
-
More Information
Article History
Received: 30 November 2020
Accepted: 21 March 2021
First Online: 16 April 2021
Declarations
:
: Analysis of tumor samples was performed following informed consent and with obscured identity (protocol #232/INT approved by institutional ethical committee). Mice experiments were approved by the Italian Minister of Health, protocol 547/2019.
: As part of the ethical committee approval, patients described in this manuscript signed to consent for publication in anonymous manner.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. A patent on the described therapeutic approach has been deposited (#102020000016321).
